Follow Us

PGT Lab

At Reproductive Genetic Innovations, it is our mission to provide patients and families with the best opportunity for a healthy pregnancy and baby while serving as a trusted partner to the physicians and care teams who support them. Together, we work to deliver clarity, confidence, and peace of mind throughout the reproductive journey.

RGI offers state-of-the-art technologies, a comprehensive range of Preimplantation Genetic Testing (PGT) and embryology services.

PGT is performed in conjunction with an In Vitro Fertilization (IVF) cycle and can significantly reduce the chances of having a baby with a specific genetic condition and/or chromosomal abnormality. There are various types of PGT available, depending on the needs of the individual couple.

 

   CAP Accreditation     Link to CLIA Certification    

 

PGT-A

for Aneuploidy

PGT-M

for Monogenic/Single Gene Defects

PGT-SR

for Structural Rearrangements

PGT-HLA

for Human Leukocyte Antigen

PGT-A

PGT-A helps identify embryos with the correct number of chromosomes before embryo transfer. PGT-A can also help lower the risk of failed implantation, miscarriage, and certain chromosome-related conditions.

PGT-M

PGT-M helps identify embryos that are not expected to be affected by a specific inherited genetic condition before pregnancy begins. This gives patients and providers valuable information when making treatment decisions and helps to reduce the risk of passing on a known genetic disorder. RGI is a leader in customized PGT-M testing and offers specialized tests for many rare and complex conditions that may not be available at other laboratories.

PGT-SR

PGT-SR helps patients who carry a chromosome rearrangement identify embryos with a balanced chromosome makeup before embryo transfer. This can help lower the risk of failed implantation, miscarriage, and certain chromosome-related conditions, giving patients and providers more confidence when making treatment decisions.

PGT-HLA

PGT-HLA may be an option for families who have a child with a genetic disorder that needs a bone marrow or cord blood transplant. The test helps identify embryos that are not expected to be affected by the condition and that may be a match for their sibling. If a match is found, stem cells from the baby's umbilical cord blood may be used to help treat the affected child.